SEC Form 4 · accession 0001405626-17-000004
Q BioMed Inc. · QBIO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Denis Corin
Officer — Chief Executive Officer · Director · 10% Owner
Period of report
Dec 5, 2017
Accepted (ET)
Dec 19, 2017 · 10:34 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001596062
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Incentive Stock OptionF1 | $4.00 | Dec 5, 2017 | A | 12,500 | A | Jun 5, 2018 | Jun 5, 2022 | Common Stock | 12,500 | 550,000 | D |
| Incentive Stock OptionF2 | $4.00 | Dec 5, 2017 | A | 25,000 | A | Jun 5, 2018 | Jun 5, 2022 | Common Stock | 25,000 | 575,000 | D |
Explanation of responses
- F1Issued for director services.
- F2Issued for officer services.